Envista (NYSE:NVST) Price Target Raised to $21.00

Envista (NYSE:NVST) had its target price upped by investment analysts at Wells Fargo & Company from $20.00 to $21.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective would suggest a potential downside of 1.25% from the stock’s previous close.

Other equities research analysts also recently issued reports about the company. Stifel Nicolaus increased their price target on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Mizuho started coverage on Envista in a report on Wednesday, December 4th. They set an “underperform” rating and a $20.00 target price on the stock. Needham & Company LLC reissued a “hold” rating on shares of Envista in a report on Thursday. Piper Sandler raised their price objective on shares of Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a research note on Monday, February 3rd. Finally, Robert W. Baird lifted their target price on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $20.21.

Envista Stock Down 2.4 %

Shares of NVST stock opened at $21.27 on Thursday. Envista has a fifty-two week low of $15.15 and a fifty-two week high of $23.06. The firm has a market capitalization of $3.66 billion, a PE ratio of -2.74, a P/E/G ratio of 1.82 and a beta of 1.34. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.08. The stock’s 50-day simple moving average is $19.96 and its 200-day simple moving average is $19.12.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. Equities analysts expect that Envista will post 0.72 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Iron Triangle Partners LP acquired a new stake in shares of Envista in the third quarter valued at approximately $43,262,000. Point72 Asset Management L.P. purchased a new stake in Envista in the 3rd quarter valued at $37,559,000. Polar Asset Management Partners Inc. increased its stake in shares of Envista by 375.6% in the 3rd quarter. Polar Asset Management Partners Inc. now owns 1,497,250 shares of the company’s stock worth $29,586,000 after acquiring an additional 1,182,450 shares during the last quarter. Pzena Investment Management LLC acquired a new position in shares of Envista during the 4th quarter valued at about $16,979,000. Finally, Franklin Resources Inc. increased its position in Envista by 26.5% during the third quarter. Franklin Resources Inc. now owns 3,971,662 shares of the company’s stock worth $78,480,000 after purchasing an additional 830,861 shares during the last quarter.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.